Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 160
Filtrar
2.
J Hosp Infect ; 118: 48-58, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34492304

RESUMEN

Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.


Asunto(s)
Microbioma Gastrointestinal , Preparaciones Farmacéuticas , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana Múltiple , Disbiosis , Humanos
5.
Anaesthesia ; 75(12): 1620-1625, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32520406

RESUMEN

Lung ultrasound could facilitate the triage of patients with suspected COVID-19 infection admitted to the emergency room. We developed a predictive model for COVID-19 diagnosis based on lung ultrasound and clinical features. We used ultrasound to image the lung bilaterally at two anterior sites, one and two hands below each clavicle, and a posterolateral site that was the posterior transverse continuation from the lower anterior site. We studied 100 patients, 31 of whom had a COVID-19 positive reverse transcriptase polymerase chain reaction. A positive test was independently associated with: quick sequential organ failure assessment score ≥1; ≥3 B-lines at the upper site; consolidation and thickened pleura at the lower site; and thickened pleura line at the posterolateral site. The model discrimination was an area (95%CI) under the receiver operating characteristic curve of 0.82 (0.75-0.90). The characteristics (95%CI) of the model's diagnostic threshold, applied to the population from which it was derived, were: sensitivity, 97% (83-100%); specificity, 62% (50-74%); positive predictive value, 54% (41-98%); and negative predictive value, 98% (88-99%). This model may facilitate triage of patients with suspected COVID-19 infection admitted to the emergency room.


Asunto(s)
Infecciones por Coronavirus/diagnóstico por imagen , Servicio de Urgencia en Hospital/estadística & datos numéricos , Pulmón/diagnóstico por imagen , Neumonía Viral/diagnóstico por imagen , Adulto , Anciano , Área Bajo la Curva , COVID-19 , Estudios de Cohortes , Infecciones por Coronavirus/diagnóstico , Servicios Médicos de Urgencia , Servicio de Urgencia en Hospital/organización & administración , Femenino , Humanos , Masculino , Persona de Mediana Edad , Puntuaciones en la Disfunción de Órganos , Pandemias , Pleura/diagnóstico por imagen , Neumonía Viral/diagnóstico , Reacción en Cadena de la Polimerasa , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y Especificidad , Triaje , Ultrasonografía
6.
Clin Exp Immunol ; 201(2): 171-186, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32324274

RESUMEN

The progression of chronic obstructive pulmonary disease (COPD), a lung inflammatory disease being the fourth cause of death worldwide, is marked by acute exacerbations. These episodes are mainly caused by bacterial infections, frequently due to Streptococcus pneumoniae. This susceptibility to infection involves a defect in interleukin (IL)-22, which plays a pivotal role in mucosal defense mechanism. Administration of flagellin, a Toll-like receptor 5 (TLR-5) agonist, can protect mice and primates against respiratory infections in a non-pathological background. We hypothesized that TLR-5-mediated stimulation of innate immunity might improve the development of bacteria-induced exacerbations in a COPD context. Mice chronically exposed to cigarette smoke (CS), mimicking COPD symptoms, are infected with S. pneumoniae, and treated in a preventive and a delayed manner with flagellin. Both treatments induced a lower bacterial load in the lungs and blood, and strongly reduced the inflammation and lung lesions associated with the infection. This protection implicated an enhanced production of IL-22 and involved the recirculation of soluble factors secreted by spleen cells. This is also associated with higher levels of the S100A8 anti-microbial peptide in the lung. Furthermore, human mononuclear cells from non-smokers were able to respond to recombinant flagellin by increasing IL-22 production while active smoker cells do not, a defect associated with an altered IL-23 production. This study shows that stimulation of innate immunity by a TLR-5 ligand reduces CS-induced susceptibility to bacterial infection in mice, and should be considered in therapeutic strategies against COPD exacerbations.


Asunto(s)
Flagelina/metabolismo , Interleucinas/metabolismo , Pulmón/metabolismo , Infecciones Neumocócicas/inmunología , Enfermedad Pulmonar Obstructiva Crónica/inmunología , Streptococcus pneumoniae/fisiología , Animales , Calgranulina A/metabolismo , Células Cultivadas , Fumar Cigarrillos/efectos adversos , Progresión de la Enfermedad , Humanos , Inmunidad Innata , Interleucina-23/metabolismo , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Receptor Toll-Like 5/agonistas , Interleucina-22
7.
Clin Exp Allergy ; 48(7): 806-813, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29603800

RESUMEN

BACKGROUND: The influence of airway remodelling and inflammation in preschoolers with severe recurrent wheeze on asthma outcomes is poorly understood. OBJECTIVE: To assess their association with asthma symptoms and lung function at school age. METHODS: Preschoolers (38.4 months) initially investigated with bronchial biopsies were re-assessed for asthma symptoms and lung function at school age. RESULTS: Thirty-six of 49 preschoolers (73.5%) were assessed at 10.9 years. Twenty-six (72.2%) had persistent asthma. Submucosal eosinophil counts were higher in children with severe exacerbations at school age than in those without (16/0.1 mm2 [11.2-30.4] vs 8/0.1 mm2 [2.4-17.6], P = .02), and correlated with the number of severe exacerbations (P = .04, r = .35). Submucosal neutrophil counts correlated with FEV1/FVC (P < .01, r = .47) and FEF25-75% predicted (P = .02, r = .43). Airway smooth muscle (ASM) area correlated with FEV1/FVC (P < .01, r = .51). Vessel numbers negatively correlated with FEV1% predicted and FEV1/FVC (P = .03, r = -.42; P = .04, r = -.41; respectively) and FEF25-75% predicted (P = .02, r = -.46). CONCLUSION: Eosinophilic inflammation in preschoolers with severe recurrent wheeze might be predictive of future severe exacerbations, neutrophilia might be associated with better lung function. Changes in ASM and vascularity might affect lung function at school age.


Asunto(s)
Remodelación de las Vías Aéreas (Respiratorias) , Asma/epidemiología , Inflamación/epidemiología , Ruidos Respiratorios , Factores de Edad , Alérgenos/inmunología , Asma/complicaciones , Asma/diagnóstico , Asma/etiología , Biomarcadores , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/inmunología , Lactante , Inflamación/etiología , Recuento de Leucocitos , Masculino , Evaluación del Resultado de la Atención al Paciente , Recurrencia , Pruebas de Función Respiratoria , Ruidos Respiratorios/etiología , Índice de Severidad de la Enfermedad , Espirometría
8.
Med Mal Infect ; 48(2): 103-113, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29191391

RESUMEN

OBJECTIVES: Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. We aimed to analyze the epithelial response to S. pneumoniae-induced lung injury. METHODS: Using an in vitro model with 16HBE cells and experimental in vivo murine model of acute lung injury, we analyzed the epithelial response to S. pneumoniae. Lung epithelial cell monolayers were exposed to S. pneumoniae and permeability was assessed by transepithelial resistance (TER) measurement and organization and expression of junction proteins. Functional consequences were studied with an in vivo murine model measuring alveolar permeability, distal alveolar fluid clearance (DAFC), and the alveolar inflammatory response. RESULTS: In vitro, S. pneumoniae induced a dose-dependent decrease in transepithelial resistance, which was associated with significant modifications in the organization of junction proteins assessed by immunofluorescence staining and expression after 6hours of exposure. In vivo, S. pneumoniae induced a transient increase in alveolar permeability with an adequate increase in DAFC 6hours post infection. In a second phase, a permanent increased permeability was associated with a major decrease in DAFC. CONCLUSION: Overall, the epithelial response to S. pneumoniae followed a biphasic pattern with an initial reversible increase in permeability related to the alteration of tight and adherens junctions and a second phase associated with an epithelial injury with a major increase in permeability with a decreased DAFC reflecting an injured alveolar capillary barrier.


Asunto(s)
Lesión Pulmonar Aguda/microbiología , Neumonía Neumocócica/complicaciones , Animales , Modelos Animales de Enfermedad , Femenino , Ratones , Ratones Endogámicos C57BL
9.
Indoor Air ; 28(2): 298-306, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29082624

RESUMEN

Azole-resistant Aspergillus fumigatus (ARAF) has been reported in patients with chronic obstructive pulmonary disease (COPD) but has not been specifically assessed so far. Here, we evaluated ARAF prevalence in azole-naïve COPD patients and their homes, and assessed whether CYP51A mutations were similar in clinical and environmental reservoirs. Sixty respiratory samples from 41 COPD patients with acute exacerbation and environmental samples from 36 of these patient's homes were prospectively collected. A. fumigatus was detected in respiratory samples from 11 of 41 patients (27%) and in 15 of 36 domiciles (42%). Cyp51A sequencing and selection on itraconazole medium of clinical (n = 68) and environmental (n = 48) isolates yielded ARAF detection in 1 of 11 A. fumigatus colonized patients with COPD (9%) and 2 of 15 A. fumigatus-positive patient's homes (13%). The clinical isolate had no CYP51A mutation. Two environmental isolates from two patients harbored TR34 /L98H mutation, and one had an H285Y mutation. Coexistence of different cyp51A genotypes and/or azole resistance profiles was detected in 3 of 8 respiratory and 2 of 10 environmental samples with more than one isolate, confirming the need for a systematic screening of all clinically relevant isolates. The high prevalence of ARAF in patients with COPD and their homes supports the need for further studies to assess the prevalence of azole resistance in patients with Aspergillus diseases in Northern France.


Asunto(s)
Contaminación del Aire Interior/análisis , Antifúngicos/farmacología , Aspergillus fumigatus/aislamiento & purificación , Azoles/farmacología , Enfermedad Pulmonar Obstructiva Crónica/microbiología , Enfermedad Aguda , Anciano , Aspergillus fumigatus/efectos de los fármacos , Aspergillus fumigatus/genética , Recuento de Colonia Microbiana , Sistema Enzimático del Citocromo P-450/efectos de los fármacos , Sistema Enzimático del Citocromo P-450/aislamiento & purificación , Progresión de la Enfermedad , Farmacorresistencia Fúngica/genética , Femenino , Proteínas Fúngicas/efectos de los fármacos , Proteínas Fúngicas/aislamiento & purificación , Genotipo , Vivienda , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos
10.
Mucosal Immunol ; 10(1): 139-149, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27143304

RESUMEN

Chronic obstructive pulmonary disease is a major health problem becoming a leading cause of morbidity and mortality worldwide. A large part of these disorders is associated with acute exacerbations resulting from infection by bacteria, such as non-typeable Haemophilus influenzae (NTHi). Our understanding of the pathogenesis of these exacerbations is still elusive. We demonstrate herein that NTHi infection of mice chronically exposed to cigarette smoke (CS), an experimental model of chronic obstructive pulmonary disease (COPD), not only causes acute pulmonary inflammation but also impairs the production of interleukin (IL)-22, a cytokine with potential anti-bacterial activities. We also report that mice lacking IL-22, as well as mice exposed to CS, have a delayed clearance of NTHi bacteria and display enhanced alveolar wall thickening and airway remodeling compared with controls. Supplementation with IL-22 not only boosted bacterial clearance and the production of anti-microbial peptides but also limited lung damages induced by infection both in IL-22-/- and CS-exposed mice. In vitro exposure to CS extract altered the NTHi-induced IL-22 production by spleen cells. This study shows for the first time that a defect in IL-22 is involved in the acute exacerbation induced by NTHi infection during experimental COPD and opens the way to innovative therapeutic strategies.


Asunto(s)
Infecciones por Haemophilus/inmunología , Haemophilus influenzae/inmunología , Interleucinas/metabolismo , Pulmón/inmunología , Enfermedad Pulmonar Obstructiva Crónica/inmunología , Remodelación de las Vías Aéreas (Respiratorias) , Animales , Carga Bacteriana , Células Cultivadas , Modelos Animales de Enfermedad , Humanos , Interleucinas/genética , Pulmón/microbiología , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Enfermedad Pulmonar Obstructiva Crónica/microbiología , Fumar/efectos adversos , Interleucina-22
11.
Chirurgia (Bucur) ; 110(2): 161-4, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26011839

RESUMEN

A portal vein invasion is no longer a contraindication for resection in pancreatic cancer, but increased morbidity and mortality rates can be encountered. Hereby it is presented the case of a patient diagnosed with a large adenocarcinoma of the uncinate process of the pancreas, who underwent aposterior approach pancreaticoduodenectomy, with en bloctang ential resection of the portal vein, and total mesopan creasexcision. A posterior approach allows a negative resection margins pancreaticoduodenectomy, with a good local control of the disease, despite the in creas.


Asunto(s)
Adenocarcinoma/cirugía , Neoplasias Pancreáticas/cirugía , Pancreaticoduodenectomía , Vena Porta/cirugía , Adenocarcinoma/patología , Carcinoma Ductal Pancreático/cirugía , Femenino , Humanos , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias Pancreáticas/patología , Pancreaticoduodenectomía/métodos , Resultado del Tratamiento
12.
Biochim Biophys Acta ; 1842(9): 1783-93, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24984282

RESUMEN

INTRODUCTION/OBJECTIVES: The role of the placenta in diabetic mothers on fetal development and programming is unknown. Prolactin (PRL) produced by decidual endometrial cells may have an impact. Although full-length PRL is angiogenic, the processed form by bone morphogenetic protein-1 (BMP-1) and/or cathepsin D (CTSD) is antiangiogenic. The objectives were to investigate the involvement of decidual PRL and its antiangiogenic fragments in placentas from type-1 diabetic women (T1D) and from pregnant diabetic rats with lower offspring weights than controls. METHODS: PRL, BMP-1, and CTSD gene expressions and PRL protein level were assessed in T1D placentas (n=8) at delivery and compared to controls (n=5). Wistar rats received, at day 7 of pregnancy, streptozotocin (STZ) (n=5) or nicotinamide (NCT) plus STZ (n=9) or vehicle (n=9). Placental whole-genome gene expression and PRL western blots were performed at birth. RESULTS: In human placentas, PRL (p<0.05) and BMP-1 (p<0.01) gene expressions were increased with a higher amount of cleaved PRL (p<0.05) in T1D than controls. In rats, diabetes was more pronounced in STZ than in NCT-STZ group with intra-uterine growth restriction. Decidual prolactin-related protein (Dprp) (p<0.01) and Bmp-1 (p<0.001) genes were up-regulated in both diabetic groups, with an increased cleaved PRL amount in the STZ (p<0.05) and NCT-STZ (p<0.05) groups compared to controls. No difference in CTSD gene expression was observed in rats or women. CONCLUSIONS: Alterations in the levels of the PRL family are associated with maternal diabetes in both rats and T1D women suggesting that placental changes in these hormones impact on fetal development.


Asunto(s)
Biomarcadores/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Placenta/metabolismo , Prolactina/metabolismo , Adulto , Animales , Western Blotting , Proteína Morfogenética Ósea 1/genética , Proteína Morfogenética Ósea 1/metabolismo , Estudios de Casos y Controles , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/patología , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patología , Femenino , Desarrollo Fetal , Humanos , Técnicas para Inmunoenzimas , Páncreas/metabolismo , Páncreas/patología , Placenta/patología , Embarazo , Prolactina/genética , ARN Mensajero/genética , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
13.
Ann Dermatol Venereol ; 141(2): 130-3, 2014 Feb.
Artículo en Francés | MEDLINE | ID: mdl-24507207

RESUMEN

BACKGROUND: Blueberry Muffin Baby is a rare neonatal cutaneous syndrome for purpuric lesions reflective of extramedullary hematopoiesis. Many causes are known, examples are congenital infections, malignancy and hematologic disorders. Langerhans' cell histiocytosis is a clonal proliferation of dendritic histiocytes. This has very rarely been associated with a Blueberry Muffin Baby presentation. CASE REPORT: We report the case of a newborn presenting with Blueberry Muffin Baby syndrome related to congenital Langherans' cell histiocytosis. At birth, he had multiple purpuric lesions on the trunk, limbs and face. Skin biopsy showed a dermal proliferation of histiocytes staining positive for S100 and CD1a. Chest and bone radiographs, and abdominal ultrasound were normal. Skin lesions have resolved in 8 weeks, the patient is in complete remission at 18 months of follow-up. DISCUSSION: A Blueberry Muffin Baby syndrome may reveal neonatal Langerhans' histiocytosis.


Asunto(s)
Hematopoyesis Extramedular , Histiocitosis de Células de Langerhans/congénito , Antígenos CD1/análisis , Histiocitos/química , Histiocitos/patología , Histiocitosis de Células de Langerhans/diagnóstico , Humanos , Recién Nacido , Masculino , Remisión Espontánea , Proteínas S100/análisis , Piel/química , Piel/patología , Síndrome
14.
Ann Dermatol Venereol ; 141(1): 43-7, 2014 Jan.
Artículo en Francés | MEDLINE | ID: mdl-24461094

RESUMEN

BACKGROUND: Cutaneous CD4+CD56+ malignant tumor proliferation was previously called "CD4/CD56 hematodermic neoplasm". However, the most recent studies have shown that the disease develops from plasmacytoid dendritic cells and the tumor has been renamed "Blastic Plasmacytoid Dendritic Cell Neoplasm" (BPDCN). It is an aggressive disease with a poor prognosis and behaves like acute leukemia in the short to moderate term. PATIENTS AND METHODS: A 65-year-old man with no particular history consulted for a left laterocervical lesion of ecchymotic aspect that had appeared one year earlier. Topical corticosteroid therapy had been unsuccessful. Examination of biopsies with lymphocyte typing enabled a diagnosis of BPDCN to be made. At the histopathological level, biopsy showed an infiltrate comprising medium to large cells. Immunohistochemical examination was remarkable for the absence of expression of markers of T- and B-cell lines. However, these tumor cells expressed CD4, CD56 and TCL1. Staging of the disease was normal. Treatment with chemotherapy was initiated in collaboration with a team of hematologists. Autologous bone marrow transplant was then performed. DISCUSSION: BPDCN is a rare malignant blood dyscrasia. It is distinguished by inaugural skin involvement, with systemic manifestations occurring much later. Histopathological examination of a skin biopsy with immunostaining establishes the diagnosis. In terms of phenotype, the tumor population is highly characteristic. The cells are negative for antigens of T- and B- cell lines. However, these cells express CD4, CD56 and TCL1, which are markers of plasmacytoid dendritic cells. The disease carries a poor prognosis and evolves in the short to middle term in the same way as acute leukemia. First-line treatment consists of the chemotherapy regimens used in aggressive lymphoma or acute leukemia. A bone marrow graft is sometimes performed at the time of initial relapse. Average survival is 12 months for chemotherapy alone and 30 months for transplant after first relapse. Early bone marrow transplantation has been shown to improve survival.


Asunto(s)
Células Dendríticas/patología , Equimosis/etiología , Dermatosis Facial/etiología , Neoplasias Hematológicas/diagnóstico , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Asparaginasa/administración & dosificación , Biomarcadores de Tumor , Biopsia , Trasplante de Médula Ósea , Antígenos CD4/análisis , Antígeno CD56/análisis , Terapia Combinada , Dexametasona/administración & dosificación , Neoplasias Hematológicas/tratamiento farmacológico , Neoplasias Hematológicas/patología , Neoplasias Hematológicas/cirugía , Humanos , Inmunofenotipificación , Masculino , Metotrexato/administración & dosificación , Proteínas Proto-Oncogénicas/análisis , Trasplante Autólogo
15.
Mucosal Immunol ; 7(3): 568-78, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24172846

RESUMEN

Chronic obstructive pulmonary disease (COPD) is a major clinical challenge mostly due to cigarette smoke (CS) exposure. Invariant natural killer T (iNKT) cells are potent immunoregulatory cells that have a crucial role in inflammation. In the current study, we investigate the role of iNKT cells in COPD pathogenesis. The frequency of activated NKT cells was found to be increased in peripheral blood of COPD patients relative to controls. In mice chronically exposed to CS, activated iNKT cells accumulated in the lungs and strongly contributed to the pathogenesis. The detrimental role of iNKT cells was confirmed in an acute model of oxidative stress, an effect that depended on interleukin (IL)-17. CS extracts directly activated mouse and human dendritic cells (DC) and airway epithelial cells (AECs) to trigger interferonγ and/or IL-17 production by iNKT cells, an effect ablated by the anti-oxidant N-acetylcystein. In mice, this treatment abrogates iNKT-cell accumulation in the lung and abolished the development of COPD. Together, activation of iNKT cells by oxidative stress in DC and AECs participates in the development of experimental COPD, a finding that might be exploited at a therapeutic level.


Asunto(s)
Activación de Linfocitos/inmunología , Células T Asesinas Naturales/inmunología , Células T Asesinas Naturales/metabolismo , Estrés Oxidativo/inmunología , Enfermedad Pulmonar Obstructiva Crónica/inmunología , Enfermedad Pulmonar Obstructiva Crónica/metabolismo , Animales , Células Presentadoras de Antígenos/inmunología , Células Presentadoras de Antígenos/metabolismo , Antioxidantes/farmacología , Derivados del Benceno/farmacología , Células Dendríticas/inmunología , Modelos Animales de Enfermedad , Humanos , Pulmón/efectos de los fármacos , Pulmón/inmunología , Pulmón/metabolismo , Pulmón/patología , Activación de Linfocitos/efectos de los fármacos , Recuento de Linfocitos , Ratones , Ratones Noqueados , Células T Asesinas Naturales/efectos de los fármacos , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Contaminación por Humo de Tabaco
16.
Ann Dermatol Venereol ; 140(12): 793-6, 2013 Dec.
Artículo en Francés | MEDLINE | ID: mdl-24315226

RESUMEN

BACKGROUND: IgA pemphigus is a particular entity among autoimmune blistering intraepidermal diseases. IgA pemphigus is subdivided into two types: intraepidermal neutrophilic IgA dermatosis and subcorneal pustular dermatosis. PATIENTS AND METHODS: We report the case of an 82-year-old woman with intraepidermal neutrophilic IgA pemphigus associated with IgA gammopathy. The histopathological findings were unusual, with numerous large subcorneal pustules, a few pustules in the stratum spinosum, and basal IgA deposition. A favourable outcome was achieved with acitretin. DISCUSSION: This observation is significant in that it highlights the difficulty of classification of IgA pemphigus, which is currently based on clinical and histopathological findings. There is currently no therapeutic consensus attitude but simply a set of empirical data.


Asunto(s)
Acitretina/uso terapéutico , Inmunoglobulina A/sangre , Cadenas kappa de Inmunoglobulina/sangre , Queratolíticos/uso terapéutico , Gammopatía Monoclonal de Relevancia Indeterminada/complicaciones , Pénfigo/tratamiento farmacológico , Anciano de 80 o más Años , Betametasona/uso terapéutico , Proteína C-Reactiva/análisis , Dapsona/uso terapéutico , Femenino , Humanos , Inmunoglobulina A/análisis , Infiltración Neutrófila , Pénfigo/complicaciones , Pénfigo/inmunología , Pénfigo/patología , Recurrencia , Piel/inmunología , Piel/patología
17.
Ann Dermatol Venereol ; 140(4): 274-7, 2013 Apr.
Artículo en Francés | MEDLINE | ID: mdl-23567228

RESUMEN

BACKGROUND: Multiple familial trichoepithelioma (MFT) is an autosomal dominant disease characterized by the development of numerous skin-coloured papules on the central area of the face. It is associated with various CYLD gene mutations that are also responsible for familial cylindromatosis and Brooke-Spiegler syndrome. PATIENTS AND METHODS: We report a novel mutation in the CYLD gene in a family with MFT and discuss new developments in therapeutic options. DISCUSSION: Recent studies indicate that CYLD is a tumour-suppressor gene.


Asunto(s)
Mutación , Síndromes Neoplásicos Hereditarios/genética , Proteínas Supresoras de Tumor/genética , Adolescente , Adulto , Crioterapia , Enzima Desubiquitinante CYLD , Francia , Heterocigoto , Humanos , Terapia por Láser , Láseres de Gas , Masculino , Síndromes Neoplásicos Hereditarios/terapia , Análisis de Secuencia de ADN , Neoplasias Cutáneas
18.
Arch Pediatr ; 20(4): 382-5, 2013 Apr.
Artículo en Francés | MEDLINE | ID: mdl-23453719

RESUMEN

We describe the case of a 4-year-old child with Mediterranean fever characterized by cutaneous features. Familial Mediterranean fever is an autosomal recessive disorder characterized by recurrent attacks of fever and polyserositis including peritonitis, pleuritis, and arthritis. Skin involvement is less common. In our case, the successively patient presented erysipelas-like erythema, edemas of the palmar and plantar regions, and purpuric lesions. From these clinical observations, several diagnoses were raised: infectious erysipelas, Kawasaki disease, Henoch-Schönlein purpura, and familial Mediterranean fever. Only the latter diagnosis was confirmed after exploration and then confirmed with genetic analysis, which found a M694V homozygous mutation. Erysipelas-like erythema is the most frequent cutaneous sign reported in the literature and the only one to be associated with the M694V homozygous mutation. The originality of this case is the dominancy and polymorphism of the skin lesions.


Asunto(s)
Fiebre Mediterránea Familiar/complicaciones , Enfermedades de la Piel/etiología , Preescolar , Humanos , Masculino
19.
Gynecol Obstet Fertil ; 40(11): 675-8, 2012 Nov.
Artículo en Francés | MEDLINE | ID: mdl-23085048

RESUMEN

Preimplantation genetic diagnosis (PGD) has been practiced for over 20 years. It prevents the birth of children with serious genetic diseases by selecting healthy embryos before pregnancy. In France, the initial indications of PGD have been extended in two directions: on the one hand, to allow identification of a mutation combined with embryo's HLA typing, to obtain, at birth, stem cells for therapeutic purposes, and on the other hand, to avoid transmission of late onset diseases without having to test the at-risk parent. Other applications are practiced worldwide but are not allowed in our country, such as social sexing. Technological developments can enable more complex diagnosis, research of several diseases or other genetic traits. It may be useful, for example, to use this possibility to add screening for Down's syndrome at any PDG in older women, when the risk is high. Other objectives were considered but presenting difficulties in their application, not only for regulatory and technical reasons, but also from an ethical point of view.


Asunto(s)
Diagnóstico Preimplantación/tendencias , Femenino , Fertilización In Vitro , Francia , Enfermedades Genéticas Congénitas/diagnóstico , Prueba de Histocompatibilidad , Humanos , Masculino , Mutación , Diagnóstico Preimplantación/ética , Preselección del Sexo/ética
20.
Prog Urol ; 22(10): 610-2, 2012 Sep.
Artículo en Francés | MEDLINE | ID: mdl-22920341

RESUMEN

We report a case of acute icteric hepatitis attributed to goserelin acetate, occurred during prostate cancer treatment. Gosereline acetate could induce acute hepatitis, which characteristics are close to autoimmune hepatitis type I and may require hepatic monitoring.


Asunto(s)
Antineoplásicos Hormonales/efectos adversos , Enfermedades Autoinmunes/inducido químicamente , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología , Goserelina/efectos adversos , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA